awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34121339-88758F19-DA5B-4D15-BE1E-65CD10B847D3
Q34121339-88758F19-DA5B-4D15-BE1E-65CD10B847D3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34121339-88758F19-DA5B-4D15-BE1E-65CD10B847D3
Novel dual Src/Abl inhibitors for hematologic and solid malignancies.
P2860
Q34121339-88758F19-DA5B-4D15-BE1E-65CD10B847D3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34121339-88758F19-DA5B-4D15-BE1E-65CD10B847D3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
434a3955cf10a86b1740ac11e574fbc090a3eea3
P2860
Dasatinib (BMS-354825), a dual SRC/ABL kinase inhibitor, inhibits the kinase activity of wild-type, juxtamembrane, and activation loop mutant KIT isoforms associated with human malignancies.